Cardiovascular 2018

Theme: One step forward towards the Advancements in Cardiovascular Medicine and Cardiac Surgery

Cardiovascular 2018

Cardiovascular2018_SP

Renowned Speakers

Jens Frahm
Max-Planck-Institut fÃ¼r biophysikalische Chemie
Germany

John P Breinholt
University of Texas McGovern Medical School
USA

Krasimira Hristova
National Heart Hospital
Bulgaria

Youssef Fathy Mohamed Nosir
King Fahad Armed Forces Hospital
Saudi Arabia

Kunlun He
Chinese PLA General Hospital
China

Magdy Abdel Hamid
Cairo University
Egypt

Mary Shibuya
Medical Editor(English) Japanese Society for Surgical Metabolism and Nutrition
Japan

Massimo Capoccia
University of Strathclyde
UK

Max Roderick
University of Birmingham Medical School
UK

Michael Griffin
University of Birmingham Medical School
UK

Mohamed Elsakka
University of Manchester
UK

Naresh Sen
Narayana Hrudayalaya Institute of Medical Science
India

Natasa Chrysodonta
Hinchingbrooke Hospital
UK

Peter Sever
Imperial College London
UK

Raimund Erbel
University Duisburg-Essen
Germany

Ram Sharan Mehta
B. P. Koirala Institute of Health Sciences
Nepal

Rohit M Sane
Madhavbaug Cardiac Rehabilitation Centre
India

Ryan M Monti
Mountainside Hospital
USA

Satoru Takeno
Kindai University Japan
Japan

Shailesh Kumar Patil
Fabiani & Budhrani Heart Institute
India

Sonal Tanwar
Rajasthan University of Health Science
India

Vincenzo Cianci
University of Swansea
UK

Yousry el-Moazamy
Prince Sultan Cardiac Center
Saudi Arabia

Jen Chen Tsai
National Yang-Ming University, School of Nursing
Taiwan

Jean-Bernard
Durand University of Texas
USA

Cristina Florescu
Craiova University of Medicine and Pharmacy
Romania

Bruce Leonard
University of Texas Medical Branch, Galveston, Texas
UK

Christy Cotner
California Baptist University
USA

M. Eileen Walsh
College of Nursing at the University of Toledo
USA

Susan George
Heart Failure Nurse Practitioner
USA

Juli Daniels
Miami Dade College BenjamÃn LeÃ³n School of Nursing
USA

Narendra Kumar
Texas A&M University, Health Science Center
USA

Guillermo R. Valdes
Miami Dade College BenjamÃn LeÃ³n School of Nursing
USA

Hilario Noveno
St. Paul University Manila Graduate School
Philippines

William E. Feeman Jr.
Wood County Hospital
USA

Stavros G Drakos
University of Utah
USA

Rainer Moosdorf
University Hospital of Giessen and Marburg
Germany

Guy Hugues Fontaine
PitiÃ©-SalpÃªtriÃ¨re Hospital
France

Suzanne L. Tinsley

USA

Jan Piek
Academic Medical Center, Amsterdam
Netherlands

John J Wang
Philips Healthcare
USA

Issam A Mikati
Northwestern University
USA

Philippe Chevalier
Louis Pradel Cardiology Hospital of Lyon
France

Jean-Pierre Usdin
American Hospital of Paris
France

Robert Skalik
Medical University of WrocÅ‚aw
Poland

Fabiola B Sozzi
University of Milan
Italy

Fekry ElDeeb
Zulekha Hospitals
UAE

Samer Ellahham
Sheikh Khalifa Medical City
UAE

Nabil Naser
Sarajevo University
Bosnia and Herzegovina

Omar Kamel Hallak
American Hospital Dubai
UAE

Amin Al-Awar
Szeged University
Hungary

Manotosh Panja
The BM Birla Heart Research Centre
India

Ashraf Reda
Menofiya University
Egypt

Ana-Catarina Pinho-Gomes
University Hospital of South Manchester
UK

Sabrina Zeghichi-Hamri
Bejaia University
Algeria

Andreas C Petropoulos
Azerbaijan State Medical University
Azerbaijan

Sameh Salama
Cairo University
Egypt

Atef Elbahry
Port Fouad Hospital â€“Port-Said
Egypt

K. K. Talwar
Max Heart Institute
India

Marie Vazquez Morgan
LSU Health School of Allied Health Professions
USA

Daniel Lichtenstein
Ambroise-ParÃ© Hospital
France

Katriina Aalto-SetÃ¤lÃ¤
University of Tampere
Finland

Anna Maria Fratta Pasini
University of Verona
Italy

Aris Lacis
University Children Hospital
Latvia

Galal Eldin Nagib-Elkilany
Gulf Medical University
UAE

Sibel Catirli Enar
Turkiye Hospital
Turkey

Alex Mota Benevides
Federal University of ABC
Brazil

Reda Mohamed
Benha University
Egypt

Arun Beeman
Great Ormond Street Childrenâ€™s Hospital
Sweden

Marco PicichÃ¨
San Camillo-Forlanini Hospital
Italy

Peter P Karpawich
Wayne State University
USA

Asma Chadli
Casablanca-Hassan II University
Morocco

Salwa Ahmed Elgebaly
Nour Heart Institue
USA

Ersoz Gonca
Bulent Ecevit University
Turkey

Ayman Raweh
Heart Center Dortmund
Germany

Pablo Avanzas
Hospital Universitario Central de Asturias
Spain

Riccardo Turri
Mirano General Hospital
Italy

Baris Cankaya
Marmara University Hospital
Turkey

Rajeev Agarwala
Jaswant Rai Speciality Hospital
India

Sara Badia
Universitari Germans Trias i Pujol
Spain

Beder Gustavo Farez
President -Echocardiography Committee Argentine Federation of Cardiology.
Argentina

Maria Kalliopi Konstantinidou
Harefield Hospital
UK

Bernhard Mumm
TOMTEC Imaging Systems
Germany

Elisabet Berastegui
Hospital Universitari Germans Trias i Pujol
Spain

Nattapong Thaiyanurak
Siriraj Hospital-Mahidol University
Thailand

Bo-Jen Chen
China Medical University
Taiwan

Aleksandra SzyliÅ„ska
Pomeranian Medical University in Szczecin
Poland

Ahmed Mostafa
Ain Shams University
Egypt

Branko Furst
Albany Medical College
USA

Ryan D Andal
Makati Medical Center
Philippines

Brojendra Agarwala
University of Chicago Medicine Comer Childrenâ€™s Hospital
USA

Farrah Pervaiz
Armed Forces Institute of Cardiology and National Institute of Heart Disease
Pakistan

Imtiaz Ahmed Chaudhry
Armed Forces Institute of Cardiology and National Institute of Heart Disease
Pakistan

Anton Cherepov
Research Institute of Space Medicine, Federal Research Clinical Center
Russia

Carola Forster
Head- Molecular Medicine Division University Hospital WÃ¼rzburg
Germany

Mizanur Rahman
Karolinska Institutet, Stockholm
Sweden

Carolina Nunes FranÃ§a
Federal University
Brazil

Cathy M Holt
University of Manchester
UK

Christoph Brune
University of Twente
Netherlands

Damien Byas
President- North American Scientific Committee on Cardiovascular Health
USA

Galya Atanasova
Professor - Medical University Pleven
Bulgaria

Irena Levitan
University of Illinois
USA

Jean Baptiste Fraison
UniversitÃ© Paris Diderot
France

Jeffrey R Bender
Yale University School of Medicine
USA

On behalf of the Organizing Committee of Cardiovascular 2017, we are delighted to be building the program again for the 3rd International Conference on Cardiovascular Medicine and Cardiac Surgery on July 05-06, 2018 in Berlin, Germany.

Our conference includes a well-balanced lineup of speakers, covering both broad and specific topics of interest. Our aims to provide cardiac physicians, specialists, nurses, technologists and anyone professionally involved in Cardiovascular Disease with an opportunity to learn about the complexity of the disease, discuss interventional procedures, look at new and advanced cardiac practices and their efficiency and efficacy in the treatment of various cases, and understand local realities and practical constraints in improving patient-care. The Cardiovascular 2018 will be organized around the theme "One step forward towards the Advancements in Cardiovascular Medicine and Cardiac Surgery". It is comprised of 20 tracks designed to offer comprehensive sessions that address current issues in Cardiovascular related affairs. Cardiology events are every year across UK, Europe, Asia, Middle East, Australia and USA that support cardiology medical conferences from 1000 more scientific societies and Publishes 500 open access journals which contains over 30000 eminent personalities, reputed scientists as editorial board members. Cardiovascular Medicine Conference 2018 comes under Cardiology medical conferences

Millions of people across the world are affected by cardiac disorders – some minor others critical. As per World Health Organization (W.H.O.) research, more than 17.5 million people have CVDs, an estimated 31% of all deaths worldwide and 80% of all CVD deaths are due to heart attacks and strokes. According to market study, the global market for Cardiovascular Disease is expected to grow from $13.7 billion to $18.2 billion by 2019. A major part of research is going on the top Universities on Cardiology across the globe. Many companies are associated with various diagnostic instruments and other therapeutics. Besides this various societies and research labs are also associated in this research field.

Track 1: Cardiovascular Medicine

Cardiovascular Conferences are the most comprehensive provider of cardiovascular services specializing in the prevention, detection, management and treatment of adult cardiovascular diseases. Cardiovascular Medicine Conferences is a platform for postgraduate education and scientific work in the fields of cardiology, angiology, hypertension and cardiac and vascular surgery.

Related Conferences 22^nd World Cardiology Conferences December 11-12, 2017 Rome, Italy; World Echo Summit 2017 4-6 October 2017 Brazil; International Heart Failure Conferences 24-25 November, 2016 Abu Dhabi, UAE; 3^rd World Heart Congress April 19-20, 2018 Amsterdam, Netherlands ; International Cardiovascular conferences January 5-7, 2018 in Bangkok, Thailand; International Conference for Innovations in Cardiovascular Systems December 3-5, 2017 Israel; CRT 2018 March 03-06,2018 Washington, DC; ASE 2018 June 22-26, 2018 Nashville, Tennessee; Cardio Rhythm 2017 February 24- 26,2017 Canadian Cardiovascular Congress, Oct 21-24, 2017, Vancouver, Canada, American Heart Association(AHA) Nov 11-15, 2017, Anaheim, California; 27^thCardiovascular Conferences February 9-14, 2018,Colorado; Clinical Cardiology Conferences, May 24-26, 2018 London, UK; Heart Surgery & Cardiology Conferences,September21-22,2017 Texas, USA; Heart Conferences, December 04-05, 2017 Dallas, Texas, USA, 25^th Euro Congress on Pediatric Heart Disease and Health, August 13-14, 2018 Dublin, Ireland; Heart Diseases Conferences, Toronto, Canada September 18-19, 2017.

Related Societies:

USA: The American Society for Preventive Cardiology; American Society of Nuclear Cardiology; American Heart Association; ACC;American Stroke Association; Society for Cardiovascular Angiography and Interventions; Arizona Society of Echocardiography; Brazilian Society of Cardiology; Heart Failure Society of America; Canadian Association of Cardiovascular Prevention and Rehabilitation; Elsevier Society Partners in Cardiology; American Society for Preventive Cardiology; American Society of Echocardiography; American Society of Hypertension; Brazilian Society of Hypertension; Canadian Cardiovascular Society; Argentine Society of Cardiology; Canadian Association of Interventional Cardiology; The American Association of Cardiovascular and Pulmonary Rehabilitation; The Society for Cardiovascular Angiography and Interventions Foundation.

Asia Pacific: Asian Pacific Society of Cardiology; Cardiac Society of Australia & New Zealand; Russian Society of Cardiology; The Japanese Heart Failure Society; Japanese Society of Echocardiography; The World Society of Cardiovascular & Thoracic Surgeons; Asian Pacific Society of Hypertension; Association of Cardiologists of Kazakhstan; Australian Cardiovascular Health and Rehabilitation Association; Association of Thoracic and Cardiovascular Surgeons of Asia; Chinese Society of Cardiology; The Pan-African Society of Cardiology (PASCAR); Association of Pediatric Cardiology; Cardiological Society of India; Asian Society of Cardiovascular Imaging; Association of Black Cardiologists; Algerian Society of Hypertension; Asian Society of Cardiothoracic Anaesthesia; Asian Society of Cardiovascular Imaging; Association of Thoracic and Cardiovascular Surgeons of Asia; Emirates Cardiac Society; Gulf Heart Association; Indian Association of Cardiovascular-Thoracic Surgeons; Indonesian Heart Association; International Cardiac Pacing and Electrophysiology Society.

Track 2: Cardiac Surgery

Innovative advancements and researches are being made in cardiac surgery every day. The world's all advanced technology and most experienced cardiovascular surgeons and cardiologists are welcome here. Cardiovascular surgeries are those which performed on the heart and circulatory system including the major veins and arteries. Cardiovascular procedures performed by cardiac surgeons.
Our Conference Cardiovascular 2017 invites worlds all cardiovascular surgeons to grace their presence in this event and share their innovative ideas at this grand international scientific platform.

Related Societies:

Track 3: Heart Diseases

Cardiovascular Disease is a major cause of disability and premature death throughout the world. The underlying pathology is atherosclerosis, which develops over many years and is usually advanced by the time symptoms occur, generally in middle age. Acute coronary events (heart attacks) and cerebrovascular events (strokes) frequently occur suddenly, and are often fatal before medical care can be given. Cardiology Conferences promotes awareness against Risk factor modification which reduces clinical events and premature death in people with established cardiovascular disease as well as in those who are at high cardiovascular risk due to one or more risk factors.

Related Conferences: 22^nd World Cardiology Conferences December 11-12, 2017 Rome, Italy; World Echo Summit 2017 4-6 October 2017 Brazil; International Heart Failure Conferences 24-25 November, 2016 Abu Dhabi, UAE; 3^rd World Heart Congress April 19-20, 2018 Amsterdam, Netherlands ; International Cardiovascular conferences January 5-7, 2018 in Bangkok, Thailand; International Conference for Innovations in Cardiovascular Systems December 3-5, 2017 Israel; CRT 2018 March 03-06,2018 Washington, DC; ASE 2018 June 22-26, 2018 Nashville, Tennessee; Cardio Rhythm 2017 February 24- 26,2017 Canadian Cardiovascular Congress, Oct 21-24, 2017, Vancouver, Canada, American Heart Association(AHA) Nov 11-15, 2017, Anaheim, California; 27^thCardiovascular Conferences February 9-14, 2018,Colorado; Clinical Cardiology Conferences, May 24-26, 2018 London, UK; Heart Surgery & Cardiology Conferences,September21-22,2017 Texas, USA; Heart Conferences, December 04-05, 2017 Dallas, Texas, USA, 25^th Euro Congress on Pediatric Heart Disease and Health, August 13-14, 2018 Dublin, Ireland; Heart Diseases Conferences, Toronto, Canada September 18-19, 2017.

Related Societies:

Track 4: Arrhythmias

An arrhythmia is a problem with the rate or rhythm of your heartbeat. It means that your heart beats too quickly, too slowly, or with an irregular pattern. When the heart beats faster than normal, it is called tachycardia. When the heart beats too slowly, it is called bradycardia. The most common type of arrhythmia is atrial fibrillation, which causes an irregular and fast heartbeat. Many factors can affect your heart's rhythm, such as having had a heart attack, smoking, congenital heart defects, and stress. Some substances or medicines may also cause arrhythmias.

Related Conferences: 22^nd World Cardiology Conferences December 11-12, 2017 Rome, Italy; World Echo Summit 2017 4-6 October 2017 Brazil; International Heart Failure Conferences 24-25 November, 2016 Abu Dhabi, UAE; 3^rd World Heart Congress April 19-20, 2018 Amsterdam, Netherlands ; International Cardiovascular conferences January 5-7, 2018 in Bangkok, Thailand; International Conference for Innovations in Cardiovascular Systems December 3-5, 2017 Israel; CRT 2018 March 03-06,2018 Washington, DC; ASE 2018 June 22-26, 2018 Nashville, Tennessee; Cardio Rhythm 2017 February 24- 26,2017 Canadian Cardiovascular Congress, Oct 21-24, 2017, Vancouver, Canada, American Heart Association(AHA) Nov 11-15, 2017, Anaheim, California; 27^thCardiovascular Conferences February 9-14, 2018,Colorado; Clinical Cardiology Conferences, May 24-26, 2018 London, UK; Heart Surgery & Cardiology Conferences,September21-22,2017 Texas, USA; Heart Conferences, December 04-05, 2017 Dallas, Texas, USA, 25^th Euro Congress on Pediatric Heart Disease and Health, August 13-14, 2018 Dublin, Ireland; Heart Diseases Conferences, Toronto, Canada September 18-19, 2017.

Related Societies:

Track 5: Molecular Cardiology

Molecular cardiology is a new and fast-growing area of cardiovascular medicine that aims to apply molecular biology techniques for the mechanistic investigation, diagnosis, prevention and treatment of cardiovascular disease. As an emerging discipline, it has changed conceptual thinking of cardiovascular development, disease etiology and pathophysiology. Although molecular cardiology is still at a very early stage, it has opened a promising avenue for understanding and controlling cardiovascular disease. With the rapid development and application of molecular biology techniques, scientists and clinicians are closer to curing heart diseases that were thought to be incurable 20 years ago. There clearly is a need for a more thorough understanding of the molecular mechanisms of cardiovascular diseases to promote the advancement of stem cell therapy and gene therapy for heart diseases. The present paper briefly reviews the state-of-the-art techniques in the following areas of molecular cardiology: gene analysis in the diseased heart; transgenic techniques in cardiac research; gene transfer and gene therapy for cardiovascular disease; and stem cell therapy for cardiovascular disease.

Related Societies:

Track 6: Hypertension

High blood pressure, also called hypertension, is a serious medical condition. It happens when the force of the blood pumping through your arteries is too strong. When your heart beats, it pushes blood through your arteries to the rest of your body. When the blood pushes harder against the walls of your arteries, your blood pressure goes up. Your blood pressure may be different at different times of the day. It is usually higher when you first wake up, after you exercise, or when you are under stress. Having higher blood pressure for short amounts of time is normal. However, when your blood pressure stays high for most of the time, it can cause serious health problems.

Related Societies:

Related 22^nd World Cardiology Conferences December 11-12, 2017 Rome, Italy; World Echo Summit 2017 4-6 October 2017 Brazil; International Heart Failure Conferences 24-25 November, 2016 Abu Dhabi, UAE; 3^rd World Heart Congress April 19-20, 2018 Amsterdam, Netherlands ; International Cardiovascular conferences January 5-7, 2018 in Bangkok, Thailand; International Conference for Innovations in Cardiovascular Systems December 3-5, 2017 Israel; CRT 2018 March 03-06,2018 Washington, DC; ASE 2018 June 22-26, 2018 Nashville, Tennessee; Cardio Rhythm 2017 February 24- 26,2017 Canadian Cardiovascular Congress, Oct 21-24, 2017, Vancouver, Canada, American Heart Association(AHA) Nov 11-15, 2017, Anaheim, California; 27^thCardiovascular Conferences February 9-14, 2018,Colorado; Clinical Cardiology Conferences, May 24-26, 2018 London, UK; Heart Surgery & Cardiology Conferences,September21-22,2017 Texas, USA; Heart Conferences, December 04-05, 2017 Dallas, Texas, USA, 25^th Euro Congress on Pediatric Heart Disease and Health, August 13-14, 2018 Dublin, Ireland; Heart Diseases Conferences, Toronto, Canada September 18-19, 2017.

Related Societies:

Track 8: Cardiovascular Engineering (CVE)

Cardiovascular Engineering stimulates innovative methods and technological advancements in the basic understanding of the cardiovascular system and in cardiovascular diagnosis and treatment applications. Original Contributions outline new concepts and applications in cardiovascular mechanics, cardiology applications and diagnostic methods, cardiac and vascular imaging, devices and instrumentation, hemodynamic monitoring and measurements, cardiac assistance, vascular grafts and artificial hearts, cardiac electrophysiology techniques, computer modeling and drug delivery systems.

Related Societies:

Track 9: Cardiac Regeneration

Cardiac Regeneration is a broad effort and comes into existence when the cardiac tissue is damaged and failed to regenerate the myocardium. Where the main principle behind cardiac regeneration is Reparative stem cells have the capability to restore function to damaged tissue by renewing cell growth in cardiac cells destroyed by heart disease. Reparative tools have been engineered to restore damaged heart tissue and function using the body's natural ability to regenerate. Current therapies includes such as adult stem and precursor cells, Nuclear dynamics of the heart growth, Reprogramming Fibroblasts to Cardiomyocytes, Stem cells and cell therapy.

Related Societies:

Track 10: Cardiac Neurodevelopment

The Cardiac Neurodevelopmental is the emerging issue, and can be observed when Children are born with complex congenital heart disease (CHD) are at risk for problems with the growth and development of their brain and central nervous system. Current therapies includes Neurodevelopmental assessment, Neuronal Biomarkers, neurodevelopmental assessment of infants. And factors that rise increase the risk of developmental delays in children undergoing open-heart surgery as a newborn or infant, Having cyanotic heart disease, premature birth, usage mechanical heart support, such as ECMO or a ventricular assist device or cardiopulmonary resuscitation, Heart transplant.

Related Societies:

Track 11: Pediatric Cardiology

In childhood a disorder which involves both the heart and lungs problems, called Pediatric Cardiopulmonary disease. Epicardial adipose tissue (EAT) is the visceral fat deposit around the heart and is commonly increased in obese subjects. EAT is related to Cardio Metabolic risk factors and non-alcoholic fatty liver disease (NAFLD) in adults, but this relationship is not well known in children. (MI) Myocardial infarction is rare in childhood and adolescence. Children usually have either an acute inflammatory condition of the coronary arteries diseases or an anomalous origin of the left coronary artery (LCA). Peripheral vascular diseases (PVDs) are circulation disorders that affect blood vessels outside of the heart and brain. In PVD, blood vessels are narrowed. Narrowing is usually caused by arteriosclerosis. We will be discussed more about the common problem of the baby heart as Cardiomyopathy, Myocarditis, Hypoplastic Left Heart Syndrome, Hypertension, Heart Murmur, Cardiac Arrest, Arrhythmogenic Right Ventricular Dysplasia, Cyanotic Heart Disease, and Paediatric Arrhythmia as well as more about Paediatric lungs disorders as Upper Airway Abnormalities, Child Interstitial Lung Disease (child), Chronic and Recurrent Respiratory Infections, Congenital Abnormalities and Paediatrics Chronic Obstructive Lung Diseases etc.

Related Societies:

Track 12: Cardiac Diagnostic Test

New tests are constantly being developed to further the understanding of disease, injury, and congenital (present at birth) or acquired abnormalities of the heart. The diagnostic tests in cardiology are methods of identifying heart conditions associated with healthy vs. unhealthy, pathologic heart function.

Related Societies:

Track 13: Cardiometabolic Health- Diabetes, Obesity, & Metabolism

The scientific goal of this track is to understand the underlying causes and pathophysiology of obesity, diabetes, and associated metabolic diseases, as well as pursuing effective and safe interventions and therapeutics. Investigators in this division also have a special emphasis on women's health and on the developmental programming of metabolic diseases. This includes expertise in the central nervous system that controls appetite and energy expenditure, pancreas function, and adipose tissue function. Our investigators utilize a broad array of research tools including noninvasive imaging, complex whole animal studies on physiology and behavior, and in vitro and ex vivo techniques.

Even though we are a small division at this time, currently consisting of 5 core scientists and 4 staff scientists, we have over $7 million (direct costs) of funding active during 2012-2013, with 70% coming from NIH and the rest from industry collaborations. Furthermore, our external collaborators have almost $2.5 million in support during that time directly related to research using our Obese NHP Resource.

Related Societies:

Track 14: Heart Failure

Heart failure, sometimes known as congestive heart failure, occurs when your heart muscle doesn't pump blood as well as it should. Certain conditions, such as narrowed arteries in your heart (coronary artery disease) or high blood pressure, gradually leave your heart too weak or stiff to fill and pump efficiently. Not all conditions that lead to heart failure can be reversed, but treatments can improve the signs and symptoms of heart failure and help you live longer. Lifestyle changes such as exercising, reducing salt in your diet, managing stress and losing weight can improve your quality of life.

One way to prevent heart failure is to control conditions that cause heart failure, such as coronary artery disease, high blood pressure, diabetes or obesity.

Related Societies:

Track 15: Nuclear Cardiology & Cardiac CT

Heart disease is the leading cause of death in the western world. Each year in the U.S.A, more than 500,000 men and women die from coronary artery disease. During the past two decades, major strides have been made in the diagnosis and treatment of heart disease. Nuclear Cardiology has played a pivotal role in establishing the diagnosis of heart disease and in the assessment of disease extent and the prediction of outcomes in the setting of coronary artery disease. Nuclear cardiology studies use noninvasive techniques to assess myocardial blood flow, evaluate the pumping function of the heart as well as visualize the size and location of a heart attack. Among the techniques of nuclear cardiology, myocardial perfusion imaging is the most widely used.

A computed tomography scan: Commonly called a CT scan or CAT scan — is a test that uses X-rays to view specific areas of your body. These scans use safe amounts of radiation to create detailed images of the body, which can help the doctor to detect any problems. A heart, or cardiac, CT scan is used to view your heart and blood vessels. A heart CT scan may also be called a coronary CT angiogram if it’s meant to view the arteries that bring blood to your heart. The test may be called a coronary calcium scan if it’s meant to determine whether there is a buildup of calcium in your heart.

Related Societies:

Track 16: Interventional Cardiology Imaging

The growth of cardiac applications of imaging techniques not traditionally handled by cardiologists such as cardiovascular magnetic resonance (CMR) and multidetector computed tomography (MSCT) requires great attention. Traditionally, cardiologists have been able to integrate all the diagnostic techniques into the cardiovascular department in order to facilitate an integrated delivery of care. To an extent this has happened also for nuclear cardiology, a field where cooperation with other nuclear medicine specialists is commonplace, but the presence of cardiology specialists during the stress examination and for the overall interpretation of results is generally accepted.

Related Societies:

Track 17: Percutaneous Cardiovascular Interventions

Percutaneous coronary intervention (PCI) is a non-surgical procedure used to treat narrowing (stenosis) of the coronary arteries of the heart found in coronary artery disease. After accessing the blood stream through the femoral or radial artery, the procedure uses coronary catheterization to visualise the blood vessels on X-ray imaging. After this, an interventional cardiologist can perform a coronary angioplasty, using a balloon catheter in which a deflated balloon is advanced into the obstructed artery and inflated to relieve the narrowing; certain devices such as stents can be deployed to keep the blood vessel open. Various other procedures can also be performed. When coronary artery disease causes chest pain or a heart attack, percutaneous coronary interventions, such as angioplasty alone or with a stent, can restore blood flow to your heart.

Related Conferences : 22^nd World Cardiology Conferences December 11-12, 2017 Rome, Italy; World Echo Summit 2017 4-6 October 2017 Brazil; International Heart Failure Conferences 24-25 November, 2016 Abu Dhabi, UAE; 3^rd World Heart Congress April 19-20, 2018 Amsterdam, Netherlands ; International Cardiovascular conferences January 5-7, 2018 in Bangkok, Thailand; International Conference for Innovations in Cardiovascular Systems December 3-5, 2017 Israel; CRT 2018 March 03-06,2018 Washington, DC; ASE 2018 June 22-26, 2018 Nashville, Tennessee; Cardio Rhythm 2017 February 24- 26,2017 Canadian Cardiovascular Congress, Oct 21-24, 2017, Vancouver, Canada, American Heart Association(AHA) Nov 11-15, 2017, Anaheim, California; 27^thCardiovascular Conferences February 9-14, 2018,Colorado; Clinical Cardiology Conferences, May 24-26, 2018 London, UK; Heart Surgery & Cardiology Conferences,September21-22,2017 Texas, USA; Heart Conferences, December 04-05, 2017 Dallas, Texas, USA, 25^th Euro Congress on Pediatric Heart Disease and Health, August 13-14, 2018 Dublin, Ireland; Heart Diseases Conferences, Toronto, Canada September 18-19, 2017.

Related Societies:

Track 18: Devices / CRT / ICD / Surgery

Implantable devices have been used for decades to treat heart disease. The first pacemaker was implanted over 40 years ago, and implantable defibrillators were first used in the early 1980s. But the last few years have witnessed a surge in both the types of devices being tested for heart-failure treatment, and in the optimism of experts about their usefulness.

An implantable cardioverter defibrillator (ICD) is a microcomputer that is implanted under the skin of your upper chest area. It is small enough to fit in the palm of your hand. It monitors your heart rate and delivers therapy in the form of small electrical pulses. A cardiac resynchronization therapy implantable cardioverter defibrillator (CRT-D) is a type of specialized ICD used to treat heart failure. Getting a cardiac resynchronization therapy (CRT) heart device is not an open-heart procedure. Before surgery, medication is usually given to make you sleepy and comfortable. The procedure is performed under local anesthesia.

Related Conferences : 22^nd World Cardiology Conferences December 11-12, 2017 Rome, Italy; World Echo Summit 2017 4-6 October 2017 Brazil; International Heart Failure Conferences 24-25 November, 2016 Abu Dhabi, UAE; 3^rd World Heart Congress April 19-20, 2018 Amsterdam, Netherlands ; International Cardiovascular conferences January 5-7, 2018 in Bangkok, Thailand; International Conference for Innovations in Cardiovascular Systems December 3-5, 2017 Israel; CRT 2018 March 03-06,2018 Washington, DC; ASE 2018 June 22-26, 2018 Nashville, Tennessee; Cardio Rhythm 2017 February 24- 26,2017 Canadian Cardiovascular Congress, Oct 21-24, 2017, Vancouver, Canada, American Heart Association(AHA) Nov 11-15, 2017, Anaheim, California; 27^thCardiovascular Conferences February 9-14, 2018,Colorado; Clinical Cardiology Conferences, May 24-26, 2018 London, UK; Heart Surgery & Cardiology Conferences,September21-22,2017 Texas, USA; Heart Conferences, December 04-05, 2017 Dallas, Texas, USA, 25^th Euro Congress on Pediatric Heart Disease and Health, August 13-14, 2018 Dublin, Ireland; Heart Diseases Conferences, Toronto, Canada September 18-19, 2017.

Related Societies:

Track 19: Cardiovascular Toxicology and Pharmacology

Cardiovascular Toxicology deals with the adverse effects on the heart or blood systems which result from exposure to toxic chemicals. It describes safety data of detrimental effects of new cardiovascular drugs. Pharmacology of vascular endothelium deals with alterations of endothelial cells and the vasculature play a central role in the pathogenesis of a broad spectrum of the most dreadful of human diseases, as endothelial cells have the key function of participating in the maintenance of patent and functional capillaries.

Related Societies:

Track 20: Clinical Cases in Cardiology

Our all Cardiology conferences has Case Studies act as informative examples to people who might also faces similar problems. Generally, Case Studies in Cardiovascular Medicine, should detail a particular medical case, reporting the background of the patient. They should discuss investigations undertaken in order to determine a diagnosis or differentiate between possible diagnoses, and should indicate the type of treatment the patient underwent as a result. In one piece we can conclude that Case Studies is an useful and informative part of every doctor or physician's medical education, which actually encourage us to include this session track on our international cardiovascular medicine conference which is going to be held at Paris, France.

Related Societies:

According to a new technical market research report, Cardiovascular Surgical Devices Technologies and Global Markets from BCC Research the global cardiovascular surgical devices market was valued at $29.7 billion in 2012 and the market growth has been increased upto $31.7 billion in 2013. BCC Research projects expected the market growth to nearly $47.2 billion by 2018, and register a five-year compound annual growth rate (CAGR) of 8.3% from 2013 to 2018.

Cardiovascular disease is the leading cause of death for both men and women in the United States, as well as in many other countries around the world. The American Heart Association estimates that 83.6 million American adults, or more than one in three, have one or more types of cardiovascular disease. Indeed, more Americans die of heart disease than of the combination of all cancers and AIDS.

In 2010, over 7.5 million inpatient cardiovascular operations and procedures were performed in the United States alone. During that year, the total inpatient hospital cost for cardiovascular disease was estimated to be $71.2 billion, about one quarter to the total cost of U.S. inpatient hospital care. The American Heart Association further estimates that, by 2030, the total direct medical costs associated with cardiovascular disease in the U.S. alone has increased from an estimated $312.6 million in 2009 to almost $1.5 trillion (in 2010 dollars).

Although incidence rates of cardiovascular disease in many European and other developed nations parallel those of the United States, many developing nations actually have much higher rates of cardiovascular disease. The World Health Organization estimates that 60% of all cardiovascular disease occurs in less developed countries. Recent increase in incidence of cardiovascular disease has been fueled by higher obesity rates in less developed countries; for example, WHO estimates that there are 70 million overweight people in China alone.Disability adjusted life years in 1990 to an estimated 82 million disability adjusted life years by 2020. This increase will be most acutely felt in nations such as Egypt, India and the republics of the former Soviet Union.

Conference Highlights

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date	July 05-06, 2018
Sponsors & Exhibitors	~~Click here for Sponsorship Opportunities~~
Speaker Opportunity Closed	Day 1	Day 2
Poster Opportunity Closed	Click Here to View